BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: John Albert M, Al-Mekhaizeem K, Neil L, Dhar R, Dhar PM, Al-Ali M, Al-Abkal HM, Haridas S. High prevalence and level of resistance to metronidazole, but lack of resistance to other antimicrobials in Helicobacter pylori, isolated from a multiracial population in Kuwait. Aliment Pharmacol Ther 2006;24:1359-66. [PMID: 17059517 DOI: 10.1111/j.1365-2036.2006.03144.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Meliț LE, Mărginean CO, Săsăran MO. The Challenges of Eradicating Pediatric Helicobacter pylori Infection in the Era of Probiotics. Children 2022;9:795. [DOI: 10.3390/children9060795] [Reference Citation Analysis]
2 Alfadhli A, Alboraie M, Afifi M, Dangi A. A randomized clinical trial comparing triple therapy versus non-bismuth based quadruple therapy for the eradication of Helicobacter Pylori in Kuwait. J Global Infect Dis 2022;14:99. [DOI: 10.4103/jgid.jgid_13_22] [Reference Citation Analysis]
3 Zurita J, Sevillano G, Paz Y Miño A, Zurita-Salinas C, Peñaherrera V, Echeverría M, Navarrete H; Helicobacter pylori Research Group. Mutations associated with Helicobacter pylori antimicrobial resistance in the Ecuadorian population. J Appl Microbiol 2021. [PMID: 34856035 DOI: 10.1111/jam.15396] [Reference Citation Analysis]
4 Farzi N, Yadegar A, Sadeghi A, Asadzadeh Aghdaei H, Marian Smith S, Raymond J, Suzuki H, Zali MR. High Prevalence of Antibiotic Resistance in Iranian Helicobacter pylori Isolates: Importance of Functional and Mutational Analysis of Resistance Genes and Virulence Genotyping. J Clin Med. 2019;8. [PMID: 31744181 DOI: 10.3390/jcm8112004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
5 Morilla AM, Álvarez-argüelles ME, Duque JM, Armesto E, Villar H, Melón S. Primary antimicrobial resistance rates and prevalence of Helicobacter pylori infection in the north of Spain. A 13-year retrospective study. Gastroenterología y Hepatología (English Edition) 2019;42:476-485. [DOI: 10.1016/j.gastre.2019.05.003] [Reference Citation Analysis]
6 Morilla AM, Álvarez-Argüelles ME, Duque JM, Armesto E, Villar H, Melón S. Primary antimicrobial resistance rates and prevalence of Helicobacter pylori infection in the north of Spain. A 13-year retrospective study. Gastroenterol Hepatol 2019;42:476-85. [PMID: 31324461 DOI: 10.1016/j.gastrohep.2019.05.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
7 Gonzalez-Hormazabal P, Musleh M, Escandar S, Valladares H, Lanzarini E, Castro VG, Jara L, Berger Z. Prevalence of clarithromycin resistance in Helicobacter pylori in Santiago, Chile, estimated by real-time PCR directly from gastric mucosa. BMC Gastroenterol 2018;18:91. [PMID: 29925321 DOI: 10.1186/s12876-018-0820-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
8 Gonzalez-hormazabal P, Musleh M, Escandar S, Valladares H, Lanzarini E, Castro VG, Jara L, Berger Z. Prevalence of dual clarithromycin and metronidazole resistance in Helicobacter pylori estimated by molecular methods in Santiago, Chile.. [DOI: 10.1101/236976] [Reference Citation Analysis]
9 Goderska K, Agudo Pena S, Alarcon T. Helicobacter pylori treatment: antibiotics or probiotics. Appl Microbiol Biotechnol. 2018;102:1-7. [PMID: 29075827 DOI: 10.1007/s00253-017-8535-7] [Cited by in Crossref: 103] [Cited by in F6Publishing: 112] [Article Influence: 20.6] [Reference Citation Analysis]
10 Kumar N, Albert MJ, Al Abkal H, Siddique I, Ahmed N. What constitutes an Arabian Helicobacter pylori? Lessons from comparative genomics. Helicobacter 2017;22. [PMID: 27277215 DOI: 10.1111/hel.12323] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
11 Alboraie M, Saad M, Al-Ali J, Malik M, Asem N, Schmidt I, Alfadhli AA. Quadruple therapy versus standard triple therapy for eradication of Helicobacter pylori in Kuwait. Arab J Gastroenterol. 2015;16:131-135. [PMID: 26611765 DOI: 10.1016/j.ajg.2015.09.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
12 Shokrzadeh L, Alebouyeh M, Mirzaei T, Farzi N, Zali MR. Prevalence of multiple drug-resistant Helicobacter pylori strains among patients with different gastric disorders in Iran. Microb Drug Resist. 2015;21:105-110. [PMID: 25303151 DOI: 10.1089/mdr.2014.0081] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
13 Fathi MS, El-folly RF, Hassan RA, El-arab ME. Genotypic and phenotypic patterns of antimicrobial susceptibility of Helicobacter pylori strains among Egyptian patients. Egyptian Journal of Medical Human Genetics 2013;14:235-46. [DOI: 10.1016/j.ejmhg.2013.03.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
14 Shokrzadeh L, Jafari F, Dabiri H, Baghaei K, Zojaji H, Alizadeh AH, Aslani MM, Zali MR. Antibiotic susceptibility profile of Helicobacter pylori isolated from the dyspepsia patients in Tehran, Iran. Saudi J Gastroenterol. 2011;17:261-264. [PMID: 21727733 DOI: 10.4103/1319-3767.82581] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
15 Lin WH, Wu CR, Fang TJ, Guo JT, Huang SY, Lee MS, Yang HL. Anti-Helicobacter pylori activity of fermented milk with lactic acid bacteria. J Sci Food Agric. 2011;91:1424-1431. [PMID: 21445876 DOI: 10.1002/jsfa.4327] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
16 Talebi Bezmin Abadi A, Ghasemzadeh A, Taghvaei T, Mobarez AM. Primary resistance of Helicobacter pylori to levofloxacin and moxifloxacine in Iran. Intern Emerg Med. 2012;7:447-452. [PMID: 21437583 DOI: 10.1007/s11739-011-0563-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
17 Al-Ali J, Al-Asfar F, Dhar R, Dhar PM, Kusum K. Diagnostic performance of gastric imprint smear for determination of Helicobacter pylori infection. Can J Gastroenterol 2010;24:603-6. [PMID: 21037989 DOI: 10.1155/2010/156310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
18 Ahmad N, Zakaria WR, Mohamed R. Analysis of antibiotic susceptibility patterns of Helicobacter pylori isolates from Malaysia. Helicobacter 2011;16:47-51. [PMID: 21241412 DOI: 10.1111/j.1523-5378.2010.00816.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
19 Farshad S, Alborzi A, Japoni A, Ranjbar R, Hosseini Asl K, Badiee P, Amin Shahidi M, Hosseini M. Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran. World J Gastroenterol 2010; 16(45): 5746-5751 [PMID: 21128326 DOI: 10.3748/wjg.v16.i45.5746] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
20 Albert MJ, Al-Akbal HM, Dhar R, De R, Mukhopadhyay AK. Genetic affinities of Helicobacter pylori isolates from ethnic Arabs in Kuwait. Gut Pathog 2010;2:6. [PMID: 20602767 DOI: 10.1186/1757-4749-2-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
21 Boyanova L, Mitov I. Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents. Expert Rev Anti Infect Ther. 2010;8:59-70. [PMID: 20014902 DOI: 10.1586/eri.09.113] [Cited by in Crossref: 78] [Cited by in F6Publishing: 88] [Article Influence: 6.5] [Reference Citation Analysis]
22 Lin W, Lin C, Sheu S, Hwang C, Ye W, Hwang W, Tsen H. Antagonistic Activity of Spent Culture Supernatants of Lactic Acid Bacteria against Helicobacter Pylori Growth and Infection in Human Gastric Epithelial AGS Cells. Journal of Food Science 2009;74:M225-30. [DOI: 10.1111/j.1750-3841.2009.01194.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
23 Alvarez A, Moncayo JI, Santacruz JJ, Santacoloma M, Corredor LF, Reinosa E. Antimicrobial susceptibility and mutations involved in clarithromycin resistance in Helicobacter pylori isolates from patients in the western central region of Colombia. Antimicrob Agents Chemother 2009;53:4022-4. [PMID: 19546360 DOI: 10.1128/AAC.00145-09] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
24 Vakil N. H. pylori treatment: new wine in old bottles? Am J Gastroenterol 2009;104:26-30. [PMID: 19098845 DOI: 10.1038/ajg.2008.91] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
25 Pan XZ, Peng XW, Peng RJ. Antibiotic resistance of Helicobacter pyloriShijie Huaren Xiaohua Zazhi 2008; 16(8): 806-813 [DOI: 10.11569/wcjd.v16.i8.806] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
26 Vakil N, Megraud F. Eradication therapy for Helicobacter pylori. Gastroenterology 2007;133:985-1001. [PMID: 17854602 DOI: 10.1053/j.gastro.2007.07.008] [Cited by in Crossref: 166] [Cited by in F6Publishing: 177] [Article Influence: 11.1] [Reference Citation Analysis]
27 [DOI: 10.1101/569814] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]